Ep. 139: Biomarkers And Personalized Medicine

A tartalmat a Thomas Frey biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Thomas Frey vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

FUTURATI PODCAST « »
Ep. 139: Biomarkers and personalized medicine | Mohit Jain

1y ago 44:31

Megosztás

MP3•Epizód kép

Dr. Mohit Jain is a physician-scientist with more than 20 years of expertise in physiology, biomedicine, engineering, computational biology, and mass spectrometry-based metabolomics. Prior to founding Sapient, he formed and was director of Jain Laboratory at the University of California San Diego (UCSD). There he led a multi-disciplinary research team to develop next-generation systems to probe the non-genetic landscape of disease, supported by over $30M in federal, foundation, and industry funding. Dr. Jain founded Sapient in 2021 as a spinout of Jain Laboratory to expand upon the mission of accelerating human discovery and drug development through the nexus of high throughput analytical mass spectrometry, computational biology, and population-level biomarker profiling.

If you enjoy this interview please subscribe to the podcast and share it with your friends, and don't forget to check out our website, futuratipodcast.com.

Learn more about your ad choices. Visit megaphone.fm/adchoices

170 epizódok

#Science #Tech #Podcasting Education #Thomas Frey